Rate of all-sites cancer incidence was 28.6 percent lower than expected during the height of the COVID-19 pandemic response
Incidence of Local-Stage Cancers Decreased From 2019 to 2022
Incidence decreased significantly for 19 of 22 cancer types, deviating from stable year-over-year changes pre-COVID-19
Early-Stage Cancer Diagnoses Decreased During First Year of COVID-19
Pattern most prominent for Hispanics, Asian American and Pacific Islanders, uninsured, those in most socioeconomically deprived areas
Biotech Company Settles With Family of Henrietta Lacks, Whose Cells Revolutionized Medicine
Henrietta Lacks’ cells were taken without her knowledge while she was a cancer patient more than 70 years ago and were the first to be successfully cloned
Cancer Patients Give Telemedicine High Marks
Patient survey shows better ratings for access and provider concern with telemedicine versus in-person visits
Changes in Cancer Risk Factors, Screening Reported During Pandemic
Declines seen in current smoking, physical inactivity, heavy alcohol consumption; increase seen in uptake of HPV vaccine, stool testing for CRC
Study Looks at Cancer-Related Death Rates During First Year of COVID-19
Decrease in death rates with cancer as underlying cause continued, while death rates with cancer as contributing cause increased
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Cancer Patients
Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities
Long COVID Seen in Most Cancer Patients After Infection
Other than female sex, no factors predict development of long-lasting symptoms
Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose computed tomographic scan rates and mammography rates below expected during March 2021 to February 2022